Biwalentne ligandy receptorów opioidowych

Journal Title: Wiadomości Chemiczne - Year 2014, Vol 68, Issue 3

Abstract

Opioids are the oldest drugs know to humanity, which have been and continue to be used for the treatment of chronic pain. Unfortunately they have a large numbers of side effects [1–6]. Three main types of opioid receptors μ (MOR), δ (DOR) and κ (KOR) are known [8]. The ORL1 receptor was classified as the fourth member of opioid receptor family [9]. Opioid receptors can form homodimers and the following heterodimers: DOR-KOR, DOR-MOR and KOR-MOR [13c,d,f, 14]. Specially designed ligands which are able to penetrate the BBB are used to study physiological consequences of opioid receptor homo- and heterodimerization, and as new analgesics. Bivalent ligands are defined as compounds that contain two pharmacophoric units, an appropriately designed spacer to separate and define the two pharmacophores, and a linker unit to connect the pharmacophores, to the spacer (Fig. 1) [16]. The affinity of a ligand to its target depends on its fundamental kinetic association and dissociation rate constants (Scheme 1) [24]. Bivalent ligands interacting with the opioid receptors have been divided into three groups: nonpeptide, peptide- nonpeptide and peptide homo- or heterodimers. Nonpeptide bivalent ligands (4–21, 27–41 and 44–45) containing different pharmacophores (selective opioid agonists or/and antagonists) connected with designed linkers have potent analgesic properties [25–34]. Compound 35 may be useful in the treatment of opioid dependence. Studies of peptide-nonpeptide ligands, which are a combination of “address” segments of endogenous opioid peptides and selective alkaloid ligand (47–50) indicate that peptide part of the analogues can modulate the receptor selectivity of the attached alkaloid pharmacophores [35]. Series of peptide-nonpeptide ligands containing different classes of opioid peptides and fentanyl (52–86) were synthesized and tested for binding affinity to μ and δ opioid receptors [38–40]. Good opioid affinity and antinociceptive activity of some of the obtained bivalent ligands (57, 61, 63) suggesting that a novel class of analgesics can be further developed utilizing this approach. Among homobivalent ligands the most important is biphalin 87 and its analogues (88–124) [41–53]. Analgesic potency of the most active ligand 112 is greater than parent peptide (biphalin) and morphine.

Authors and Affiliations

Oliwia Frączak, Aleksandra Olma

Keywords

Related Articles

Aktywność biologiczna pochodnych 2,7-naftyrydyny

2,7-Naphthyridine is one of the six structural isomers of pyridopyridines. More than one hundred years ago, Gabriel and Colman discovered the isomer 2,7-naphthyridine, and named it “copiryne” [3]. From among of all napht...

Prolina : pospolity aminokwas wyjątkowy katalizator. Część IV, Reakcja Michaela

In recent years there has been a dynamic development of asymmetric synthesis. Groups of researchers, particularly the one led by Benjamin List and Carlos Barbas, carried out a number of reactions and showed the effective...

Alkaloidy kory chinowej : małe cząsteczki, które wiele mogą

Cinchona alkaloids comprising quinine, quinidine, cinchonidine and cinchonine as the major members constitute a unique class of quinoline alkaloids with tremendous impact on human civilization (Section 1). The odyssey of...

Spektrometria mas w badaniach skażeń mikrobiologicznych środowiska. Część 2, Kwasy 3-hydroksytłuszczowe jako biomarkery lipopolisacharydów (endotoksyn) ścian komórkowych bakterii gramujemnych

Microorganisms synthesize several monomeric chemical structures that are not found elsewhere in nature, e.g. muramic acid (an amino sugar) and D-amino acids (D-alanine and D-glutamic acid) are ubiquitous in bacterial pep...

Download PDF file
  • EP ID EP585230
  • DOI -
  • Views 142
  • Downloads 0

How To Cite

Oliwia Frączak, Aleksandra Olma (2014). Biwalentne ligandy receptorów opioidowych. Wiadomości Chemiczne, 68(3), 233-255. https://europub.co.uk/articles/-A-585230